Avery Dennison Medical showcased its pressure-sensitive adhesive (PSA) materials at Medica 2023. The company showcased its range of products for multiple wearable device applications, including diabetes management, remote vital signs sensing, multi-day drug delivery and other Internet of Things (IoT) digital healthcare solutions.
Surgical Solutions for Medical Device OEMs
Avery Dennison Medical also showcased its adhesive-based surgical solutions for medical device OEMs. Its portfolio of products in this area includes incise films, construction tapes, and drape tapes for bordering or fenestration.
All of these adhesives undergo meticulous biocompatibility testing in strict accordance with ISO 10993, guaranteeing their safety for
medical applications.
“
We have a broad portfolio of skin contact, tie-layer device and cover tapes, including ready-to-use materials for both short-term and extended-wear devices. The company exhibited its extensive portfolio of products, created specifically to meet the needs of a wide array of wearable device applications,” said Miguel Solivan, marketing manager for Avery Dennison Medical.
With patient safety at the forefront, “
We understand that surgical tape must excel in secure adhesion, reducing the risk of infections while maintaining biocompatibility,” said product manager Rachel Jacobs. “
This ensures it aligns with the specific requirements of sedated patients and the practical needs of surgeons and nurses.”
Products Manufactured in ISO 13485-certified Facilities
The company notes that all of its surgical tape products are sterilizable by gamma and ethylene oxide (ETO) processes, adding to the versatility of its offerings. Additionally, it manufactures all such products in ISO 13485-certified manufacturing facilities in the European Union and North America. Those same facilities are also fully compliant with Good Manufacturing Practices (GMP), underscoring its commitment to excellence in medical device manufacturing.
“
We look forward to helping the OEMs there to streamline their path from development to commercialization,” said general manager John Gaffney.
Source: Avery Dennison Medical